Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03326713 · ClinicalTrials.gov registry record · NA
Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 668
- Enrollment target
NCT03326713: Completed NA study, sponsored by Rutgers, The State University of New Jersey.
NCT03326713 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 668 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03326713, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 668 participants
- Enrollment target
Study Summary
GRACE is a randomized 3-arm trial to determine the comparative effectiveness of two remote cancer communication interventions: 1) a targeted generic print (TP) or 2) a tailored telephone-based counseling and navigation intervention (TCN). Post-award, the target sample size was revised to (n=642) with NIH permission.
Primary Outcome
Participants reported whether they had sought cancer CGRA (i.e. genetic counseling and/or testing) in surveys at the 6-month follow-up. Participants who reported receiving a CGRA were asked to provide written consent allowing research staff to obtain document of receipt of the genetic services.
Interventions
- OTHER Usual Care (UC)
- BEHAVIORAL Telephone Counseling & Navigation (TCN)
- BEHAVIORAL Mailed Targeted Print (TP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 668 participants |
| Start Date | 2017-11-02 |
| Est. Completion | 2022-06-02 |
| Phase | NA |
What the finished NCT03326713 record still lists
NCT03326713 is an interventional study that assigns participants to a tested intervention. The registered 668 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower).
The record links to 0 conditions, and to 3 interventions - of which Usual Care (UC) is the first listed.
NCT03326713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03326713 about?
NCT03326713 is a clinical study titled "Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project". GRACE is a randomized 3-arm trial to determine the comparative effectiveness of two remote cancer communication interventions: 1) a targeted generic print (TP) or 2) a tailored telephone-based counseling and navigation intervention (TCN). Post-award, the target sample size was revised to (n=642) wit...
What is the current status of trial NCT03326713?
This trial is currently completed. It is a NA study. The enrollment target is 668 participants. The study started on 2017-11-02. Estimated completion is 2022-06-02.
What interventions are being tested in trial NCT03326713?
The interventions under investigation include: Usual Care (UC) (OTHER), Telephone Counseling & Navigation (TCN) (BEHAVIORAL), Mailed Targeted Print (TP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03326713?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03326713's enrollment target sits among peer trials
668 154th of 2000 higher than 1,846 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04155034 · 668 participants · Phase 3
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
- NCT04179981 · 668 participants · NA
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- NCT05006482 · 668 participants · Phase 3
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- NCT02984761 · 670 participants · NA
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI